Boji Medical Technology Co.,Ltd. Stock: price and insider trades · China
博济医药
Boji Medical Technology Co.,Ltd.: what insiders have been doing
This page follows insider dealings at Boji Medical Technology Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. From 5 November 2025 to 5 November 2026, the disclosure feed for Boji Medical Technology Co.,Ltd. logged 1 filing by 1 insider.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €1.8M. The largest single trade was a sale of €1.8M by 横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金, published on 3 December 2025.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Across the 519 companies tracked on its exchange, the median is 2 filings; at 1 filing, this issuer sits below that mark. The full history, which starts in 2021, counts no purchases against 5 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,707,900 shares100.0% of flowA股XSHESZSE:173000009857030400
- 189,500 shares16.8% of flowA股XSHESZSE:173000009858838620
- 288,600 shares24.2% of flowA股XSHESZSE:173000005073039400
- 353,600 shares28.9% of flowA股XSHESZSE:173000005073039360
- 557,000 shares30.2% of flowA股XSHESZSE:173000004826263400
5 of 5 declarations
About Boji Medical Technology Co.,Ltd.
博济医药 is a company specialized in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations